Search - tctmd.com

Displaying 581 - 600 of 900

Sort: Relevancy | Date

Presentation

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Presenter: Gilles Lemesle

July 02, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

Presentation

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Presenter: J.B. Byrd

June 16, 2014

Presentation

Efficacy, Safety of Rivaroxaban vs Warfarin in Elderly Patients with Nonvalvular A-fib

Presenter: Jonathan L. Halperin

June 09, 2014

Presentation

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Presenter: Nicholas L. Cruden

May 28, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Presenter: G. El-Hayek

May 19, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

Presentation

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Presenter: K. Goto

April 30, 2014

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

Preprocedural Statin Use in PCI Patients

Presenter: M. Kenaan

April 21, 2014

Presentation

The Efficacy of Ticagrelor Is Maintained in Women with ACS Participating in the PLATO trial

Presenter: Steen Husted

April 16, 2014

Presentation Fellows 2014

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: George Dangas

April 12, 2014

Presentation Fellows 2014

Antithrombin Pharmacology for the Interventionalist

Presenter: Sunil Rao

April 12, 2014

Presentation

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Presenter: J.P. Loh

April 11, 2014

Presentation

Intracoronary Thrombolysis in STEMI Patients with Massive Intraluminal Thrombus, Failed Aspiration

Presenter: Daniella Boscarelli

April 10, 2014

Presentation

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

Presenter: Dimitrios Alexopoulos

April 09, 2014

Presentation

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

Presenter: Philippe Généreux

April 02, 2014

Presentation ACC 2014

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Presenter: Philippe Généreux

March 30, 2014

Advertisement

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Efficacy, Safety of Rivaroxaban vs Warfarin in Elderly Patients with Nonvalvular A-fib

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Preprocedural Statin Use in PCI Patients

The Efficacy of Ticagrelor Is Maintained in Women with ACS Participating in the PLATO trial

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Intracoronary Thrombolysis in STEMI Patients with Massive Intraluminal Thrombus, Failed Aspiration

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content